Welch & Forbes LLC Scholar Rock Holding Corp Transaction History

Welch & Forbes LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 19, 2022	SELL	$24.14 - $35.18 $181,050 - $263,850	-7,500 Closed	0 $0
Q4 2020 Jan 20, 2021	SELL	$13.72 - $51.57 $41,160 - $154,710	-3,000 Reduced 28.57%	7,500 $364,000
Q3 2020 Oct 23, 2020	BUY	$10.54 - $18.47 $110,669 - $193,935	10,500 New	10,500 $186,000

175

75.6M

585K

862K

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $2.17B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

Get notified when there are updates to the investment portfolio of Welch & Forbes LLC, based on Form 13F filings with the SEC.

Stay updated on Welch & Forbes LLC with notifications on news.